US20190343620A1 - Mesh pouch for medical implant - Google Patents
Mesh pouch for medical implant Download PDFInfo
- Publication number
- US20190343620A1 US20190343620A1 US16/520,879 US201916520879A US2019343620A1 US 20190343620 A1 US20190343620 A1 US 20190343620A1 US 201916520879 A US201916520879 A US 201916520879A US 2019343620 A1 US2019343620 A1 US 2019343620A1
- Authority
- US
- United States
- Prior art keywords
- mesh
- pouch
- wall
- opening
- mesh pouch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses and implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0057—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof stretchable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0071—Three-dimensional shapes spherical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/04—Materials or treatment for tissue regeneration for mammary reconstruction
Definitions
- the present disclosure relates generally to mesh coverings for implants and, more particularly, to a mesh pouch for an implant.
- the present disclosure relates to field of surgically implantable devices. Aspects of this disclosure specifically relate to the support and stabilization of a breast prosthesis using bioabsorbable, flexible mesh pouches.
- Synthetic implants composed of silicone or saline are commonly used in both breast augmentation and reconstruction, but in both cases the soft tissue envelope alone is sometimes insufficient to keep the implant in the appropriate location. Further, in many cases it is difficult to achieve or maintain an anatomically appropriate breast shape when a round implant is used. Due to these deficiencies in native tissue, a revision surgery is sometimes needed to reshape, reposition, lift, or otherwise modify the implant and/or periprosthetic tissue. A revision surgery could be avoided if an additional, shaping, localizing support structure for the breast implant was provided. An internal bra in a sling or a hammock configuration is sometimes used to provide additional support for the breast implant over time. Common materials for the internal bra hammock are surgical mesh and decellularized tissue.
- FIG. 1 is a top view of a mesh pouch configured in accordance with an embodiment.
- FIG. 2 is a perspective close-up of an opening of the mesh pouch along with a drawstring.
- FIG. 3 is a perspective rear view of the mesh pouch.
- FIG. 4 is a rear view of the mesh pouch.
- FIG. 5 and FIG. 6 depict a method for using the mesh pouch in surgery, according to an embodiment.
- the disclosure is generally directed to a mesh pouch for securing an implant with a patient's body.
- the mesh pouch includes a mesh wall that defines an enclosure having an opening.
- the mesh pouch further includes a drawstring configured to close the opening when drawn so as to prevent the surgical implant from leaving the enclosure.
- the mesh pouch may further include a mesh tab extending from the mesh wall, the mesh tab providing a surface for suturing the mesh pouch to an inner surface of the patient's body.
- the mesh pouch may further include a strand extending from the mesh wall and a needle attached to a terminus of the strand. The strand may be configured to tighten the mesh wall around the surgical implant when pulled.
- the mesh pouch disclosed herein provides extra support and stabilization. After the implant is inserted into the mesh pouch and the tabs are sutured to the chest wall, the 360 degree mesh enclosure keeps the implant localized for the duration of the healing process and alleviates the surrounding soft tissues of the weight of the implant. This latter benefit is particularly advantageous in post-mastectomy breast reconstruction, which is commonly performed in a setting of tenuous blood supply to the skin flaps that remain.
- the tabs on the outside wall of the mesh pouch provide additional surface area to suture and support the encased breast implant, without running the risk of puncturing the implant by suturing directly through the outer wall of the pouch.
- the pouch method described herein can fully bear the weight of the implant, force the implant into the desired shape, and keep the implant localized medio-laterally. Further, it is more time-efficient to put an implant into a pre-shaped pouch, cinch it closed, and suture a small number of tabs in place than it is to cut a custom hammock or sling out of a flat sheet, and then tailor it into the hemi-pocket of the appropriate size and shape for the given implant and soft tissue deficit.
- Various embodiments of the mesh pouch include one or more drawstrings around an opening, which can be pulled to close the opening.
- a drawstring design allows the walls of the mesh pouch to fit flush against an implant. This design helps to eliminate bunched up material and resulting air pockets, which can cause bacterial infection, and swelling.
- Embodiments of the mesh pouch described herein have no resorbable coating. Instead, embodiments described herein are completely constructed of a bioabsorbable material. Having the entire device constructed from a bioabsorbable material can cut down on complications and infections commonly seen from a non-bioabsorbable mesh implant.
- the mesh pouch includes a mesh wall 102 that surrounds and defines an enclosure 104 .
- the mesh wall 102 is spheroid in shape when fully expanded, but is configured to conform to the shape of an implant when in use.
- the mesh wall 102 has an opening 106 at an end 108 , through which an implant (such as a breast implant or other mammary prosthesis, such as a tissue expander) may be inserted.
- an implant such as a breast implant or other mammary prosthesis, such as a tissue expander
- the mesh wall 102 is made up of a first series of circular cords 110 that surround a longitudinal axis A of the mesh pouch 100 , and which are smallest in circumference at opposite ends 108 and 112 of the mesh pouch 100 and largest in circumference around the center 114 of the mesh pouch 100 .
- the mesh wall 102 is further made up of a second series of circular cords 116 , which are oriented in planes that are perpendicular to the planes of orientation of the first series circular cords 110 .
- the mesh wall 102 is still further made up of a third series of circular cords 118 , which are oriented in planes that are perpendicular to the planes of orientation of both the first set of circular cords 110 and the second series of circular cords 116 .
- the second and third series of circular cords 116 and 118 are discontinuous in places where the opening 106 interrupts them.
- the mesh wall 102 comprises a porous material, such as knitted surgical mesh. It is configured to maintain a three-dimensional configuration, such as a breast-shape or a sphere-shape, independent of the presence of a surgically-implanted device. It may be made of a stretchable material that allows expansion of the opening 106 and subsequent contraction of the opening 106 to or near its original size.
- the mesh wall 102 may be made of a bioabsorbable material such as poly-(p)-dioxanone, poly-trimethylene-carbonate, polyglycolide, etc. It may also be composed of a biologic material. including complex extracellular matrices and simple polymers such as P4HB, fibroin, etc. It may also be composed of a permanent synthetic material such as polypropylene, polyester, or expanded polytetrafluoroethylene.
- the mesh wall 102 incorporates a macroporous material (i.e., in which the pores are visible to the naked eye) that strongly encourages tissue growth, localizing and shaping the implant.
- the degree of porosity is one of the main determinants of tissue reaction.
- the pores of the mesh wall extend over the entire surface of the mesh wall and are greater than 70 ⁇ m (micrometers or microns) in diameter in order to facilitate neovascularization and neocollagenesis and to promote infiltration by macrophages and fibroblasts.
- Such a macrophage and fibroblast response facilitates the tissue incorporation process and functional remodeling of implanted materials.
- each of the pores of the mesh wall 102 is 800 microns or greater in diameter. Having such a large pore size facilitates increased soft tissue ingrowth and avoids granuloma bridging, which often leads to a stiff scar plate and reduced flexibility. This phenomenon often occurs in meshes with a pore size of less than 800 ⁇ m.
- the mesh wall 102 is of a single-piece construction (i.e., not multiple wall pieces attached together).
- a drawstring 120 proximate to and surrounding the opening 106 is a drawstring 120 which, when pulled away from the mesh wall 102 , closes the opening 106 sufficiently to prevent an implant from leaving the enclosure 106 .
- the drawstring 120 is secured to the mesh wall 102 by a sleeve 122 (which may be made of solid material or may be made of a series of threaded loops).
- the drawstring 120 has a first free portion 124 and a second free portion 126 , each of which is free from the sleeve 122 . In order to close the opening 106 , one or both of the free portions 124 and 126 are pulled away from the mesh wall 102 .
- the drawstring 120 may be attached to the mesh wall 102 via one or more openings along the edge of the opening 106 (e.g., sufficiently dimensioned so that a cord or string can be passed through and pulled to close the opening of the pouch in a drawstring or purse string fashion).
- material around the opening 106 has elastic properties conferred by the textile characteristics of the mesh wall 102 (e.g., at the rim of the opening) such that a surgical implant may be placed in the enclosure 106 by forcibly widening opening and inserting the implant. The implant is then trapped by the retraction of the opening.
- This embodiment may or may not include a drawstring.
- the mesh pouch 100 includes one or more extensions, shown in the figures as a first mesh tab 128 and a second mesh tab 130 .
- the mesh tabs 128 and 130 are attached to the mesh wall 102 on opposite sides of the widest point of the mesh pouch 100 .
- the mesh tabs 128 and 130 provide surfaces for suturing the mesh pouch 100 to interior portions (e.g., internal tissue) of a patient.
- the pore sizes and pattern of the mesh tabs may vary depending on the embodiment. Two mesh tabs are shown in the drawings, but additional mesh tabs are possible in other embodiments.
- the mesh tabs 128 and 130 are placed on the same plane halfway (or approximately halfway) through the cross of the spheroid shape of the mesh pouch 100 .
- Other embodiments may have the mesh tabs placed on different planes or at different cross-sectional lengths along the diameter of the mesh pouch.
- the mesh pouch 100 includes an integrated strand 132 attached to the mesh wall 102 .
- the strand 132 has a needle 134 attached to its terminus.
- the strand 132 may be used to suture the mesh pouch 100 to an interior portion of a patient.
- the strand 132 is connected to one or more of the cords of the mesh wall 102 (either with a sleeve configuration such as the drawstring 120 or without a sleeve) so that pulling the strand 132 (e.g., while suturing using the strand) has the effect of making the enclosure 104 smaller so that the mesh wall 102 fits more snugly onto an implant.
- the mesh pouch 100 may have multiple such integrated strands with needles.
- a medical device such as a breast implant is inserted into the mesh pouch 100 through the opening 106 .
- the drawstring 120 is pulled such that the opening 106 becomes increasingly small as the drawstring 120 is pulled tighter until it is tight.
- the drawstring 120 is then cinched.
- the implant may be held within the mesh pouch 100 due to the elastic recoil of the mesh wall 102 , or more firmly by closure of opening 106 with the drawstring 120 .
- the resting shape of the mesh wall 102 may force a round implant enclosed in this way to take on a more natural breast shape.
- the implant within the mesh pouch 100 can then be placed in the appropriate position and appropriate tissue plane as it would be without the mesh pouch 100 (between the skin and the pectoralis/fascia in the setting of prepectoral breast reconstruction, for example).
- the integrated mesh tabs 128 and 130 can be sutured directly to the soft tissue (an interior the chest wall or other tissue, such as the pectoralis fascia, for example) in order to maintain its position during the healing process.
- the suturing of the mesh pouch 100 to the chest wall provides a way to localize the implant without having to rely on soft tissue manipulation, and the position of the tabs distant from the breast prosthesis minimizes the risk of accidental damage to the breast prosthesis during this process.
- Positioning and shaping may be further facilitated by the use of the integrated needle 134 (or needles, if there are multiple) to suture to the chest wall, which (if integrated with the mesh wall 102 as described above) also cinches down or tailors the mesh pouch 100 as desired by the tightening of strands (e.g., integrated fibers) to which the integrated needles are attached. Finally, the overlying layers (skin and subcutaneous tissue, for example), are closed. The weight of the implant is borne by the mesh pouch 100 and the soft tissue to which it is sutured, rather than the skin envelope that is covering it.
- the integrated needle 134 or needles, if there are multiple
- the mesh pouch 100 is formed as follows: 1) A mesh sheet is formed by warp knitting, electrospinning, or other textile technique. 2) A thermally conductive mold or mandril is formed in a desired spheroid or breast shape. 3) The mesh is wrapped around and annealed to the mold or mandril to the desired spheroid or breast shape.
- the mesh pouch 100 may have uses in multiple domains of breast surgery, such as direct-to-implant, prepectoral, breast reconstruction for a mastectomy defect.
- recreation of the breast mound is performed by placing a prosthetic breast implant in the plane between the pectoralis muscle and the overlying skin, in the space where breast tissue used to reside prior to the mastectomy.
- a mesh-pouched implant 500 (configured according to one or more of the previously described embodiments) disposed in situ in a human breast, with a retractor 502 also shown.
- FIG. 5 there is depicted a mesh-pouched implant 500 (configured according to one or more of the previously described embodiments) disposed in situ in a human breast, with a retractor 502 also shown.
- FIG. 6 there is depicted a mesh-pouched implant 600 (configured according to one or more of the previously described embodiments) disposed in situ in a human breast with a mesh tab 602 sutured in place.
- the various tissue shown in FIG. 6 includes skin and subcutaneous tissue 604 , pectoralis 606 , ribs 608 , and intercostals 610 .
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Prostheses (AREA)
Abstract
Description
- The present application is a continuation-in-part of U.S. application Ser. No. 16/186,785, filed on Nov. 12, 2018 (now U.S. Pat. No. 10,363,127), which claims the priority benefit of U.S. Provisional Patent Application 62/585,402, filed on Nov. 13, 2017. The above-referenced documents are incorporated herein by reference in their entirety.
- The present disclosure relates generally to mesh coverings for implants and, more particularly, to a mesh pouch for an implant.
- The present disclosure relates to field of surgically implantable devices. Aspects of this disclosure specifically relate to the support and stabilization of a breast prosthesis using bioabsorbable, flexible mesh pouches.
- Synthetic implants composed of silicone or saline are commonly used in both breast augmentation and reconstruction, but in both cases the soft tissue envelope alone is sometimes insufficient to keep the implant in the appropriate location. Further, in many cases it is difficult to achieve or maintain an anatomically appropriate breast shape when a round implant is used. Due to these deficiencies in native tissue, a revision surgery is sometimes needed to reshape, reposition, lift, or otherwise modify the implant and/or periprosthetic tissue. A revision surgery could be avoided if an additional, shaping, localizing support structure for the breast implant was provided. An internal bra in a sling or a hammock configuration is sometimes used to provide additional support for the breast implant over time. Common materials for the internal bra hammock are surgical mesh and decellularized tissue.
- These internal bras provide additional support for the breast implant, but improved support and stabilization are still needed to ensure long-lasting results in breast augmentation and reconstruction procedures.
- While the appended claims set forth the features of the present techniques with particularity, these techniques may be best understood from the following detailed description taken in conjunction with the accompanying drawings of which:
-
FIG. 1 is a top view of a mesh pouch configured in accordance with an embodiment. -
FIG. 2 is a perspective close-up of an opening of the mesh pouch along with a drawstring. -
FIG. 3 is a perspective rear view of the mesh pouch. -
FIG. 4 is a rear view of the mesh pouch. -
FIG. 5 andFIG. 6 depict a method for using the mesh pouch in surgery, according to an embodiment. - The disclosure is generally directed to a mesh pouch for securing an implant with a patient's body. According to various embodiments, the mesh pouch includes a mesh wall that defines an enclosure having an opening. The mesh pouch further includes a drawstring configured to close the opening when drawn so as to prevent the surgical implant from leaving the enclosure. The mesh pouch may further include a mesh tab extending from the mesh wall, the mesh tab providing a surface for suturing the mesh pouch to an inner surface of the patient's body. The mesh pouch may further include a strand extending from the mesh wall and a needle attached to a terminus of the strand. The strand may be configured to tighten the mesh wall around the surgical implant when pulled.
- The mesh pouch disclosed herein provides extra support and stabilization. After the implant is inserted into the mesh pouch and the tabs are sutured to the chest wall, the 360 degree mesh enclosure keeps the implant localized for the duration of the healing process and alleviates the surrounding soft tissues of the weight of the implant. This latter benefit is particularly advantageous in post-mastectomy breast reconstruction, which is commonly performed in a setting of tenuous blood supply to the skin flaps that remain. The tabs on the outside wall of the mesh pouch provide additional surface area to suture and support the encased breast implant, without running the risk of puncturing the implant by suturing directly through the outer wall of the pouch. Compared to the hammock method, which only provides support and localization in the cranio-caudal plane, the pouch method described herein can fully bear the weight of the implant, force the implant into the desired shape, and keep the implant localized medio-laterally. Further, it is more time-efficient to put an implant into a pre-shaped pouch, cinch it closed, and suture a small number of tabs in place than it is to cut a custom hammock or sling out of a flat sheet, and then tailor it into the hemi-pocket of the appropriate size and shape for the given implant and soft tissue deficit.
- Various embodiments of the mesh pouch include one or more drawstrings around an opening, which can be pulled to close the opening. Using a drawstring design allows the walls of the mesh pouch to fit flush against an implant. This design helps to eliminate bunched up material and resulting air pockets, which can cause bacterial infection, and swelling.
- Embodiments of the mesh pouch described herein have no resorbable coating. Instead, embodiments described herein are completely constructed of a bioabsorbable material. Having the entire device constructed from a bioabsorbable material can cut down on complications and infections commonly seen from a non-bioabsorbable mesh implant.
- The various embodiments described herein provide patients with longer-lasting results from breast augmentation or reconstruction, which reduces the need for subsequent revision surgeries.
- Turning to
FIGS. 1-4 , a mesh pouch according to an embodiment is illustrated. The mesh pouch, generally labeled 100, includes amesh wall 102 that surrounds and defines anenclosure 104. Themesh wall 102 is spheroid in shape when fully expanded, but is configured to conform to the shape of an implant when in use. Themesh wall 102 has anopening 106 at anend 108, through which an implant (such as a breast implant or other mammary prosthesis, such as a tissue expander) may be inserted. - In an embodiment, the
mesh wall 102 is made up of a first series ofcircular cords 110 that surround a longitudinal axis A of themesh pouch 100, and which are smallest in circumference atopposite ends mesh pouch 100 and largest in circumference around thecenter 114 of themesh pouch 100. Themesh wall 102 is further made up of a second series ofcircular cords 116, which are oriented in planes that are perpendicular to the planes of orientation of the first seriescircular cords 110. Themesh wall 102 is still further made up of a third series ofcircular cords 118, which are oriented in planes that are perpendicular to the planes of orientation of both the first set ofcircular cords 110 and the second series ofcircular cords 116. The second and third series ofcircular cords - In an embodiment, the
mesh wall 102 comprises a porous material, such as knitted surgical mesh. It is configured to maintain a three-dimensional configuration, such as a breast-shape or a sphere-shape, independent of the presence of a surgically-implanted device. It may be made of a stretchable material that allows expansion of the opening 106 and subsequent contraction of theopening 106 to or near its original size. Themesh wall 102 may be made of a bioabsorbable material such as poly-(p)-dioxanone, poly-trimethylene-carbonate, polyglycolide, etc. It may also be composed of a biologic material. including complex extracellular matrices and simple polymers such as P4HB, fibroin, etc. It may also be composed of a permanent synthetic material such as polypropylene, polyester, or expanded polytetrafluoroethylene. - In an embodiment, the
mesh wall 102 incorporates a macroporous material (i.e., in which the pores are visible to the naked eye) that strongly encourages tissue growth, localizing and shaping the implant. The degree of porosity is one of the main determinants of tissue reaction. According to an implementation, the pores of the mesh wall extend over the entire surface of the mesh wall and are greater than 70 μm (micrometers or microns) in diameter in order to facilitate neovascularization and neocollagenesis and to promote infiltration by macrophages and fibroblasts. Such a macrophage and fibroblast response facilitates the tissue incorporation process and functional remodeling of implanted materials. - According to an embodiment, each of the pores of the
mesh wall 102 is 800 microns or greater in diameter. Having such a large pore size facilitates increased soft tissue ingrowth and avoids granuloma bridging, which often leads to a stiff scar plate and reduced flexibility. This phenomenon often occurs in meshes with a pore size of less than 800 μm. - In an embodiment, the
mesh wall 102 is of a single-piece construction (i.e., not multiple wall pieces attached together). - According to an embodiment, proximate to and surrounding the
opening 106 is adrawstring 120 which, when pulled away from themesh wall 102, closes theopening 106 sufficiently to prevent an implant from leaving theenclosure 106. Turning toFIG. 2 , thedrawstring 120 is secured to themesh wall 102 by a sleeve 122 (which may be made of solid material or may be made of a series of threaded loops). Thedrawstring 120 has a firstfree portion 124 and a secondfree portion 126, each of which is free from thesleeve 122. In order to close theopening 106, one or both of thefree portions mesh wall 102. Instead of asleeve 122, thedrawstring 120 may be attached to themesh wall 102 via one or more openings along the edge of the opening 106 (e.g., sufficiently dimensioned so that a cord or string can be passed through and pulled to close the opening of the pouch in a drawstring or purse string fashion). - In an embodiment, material around the
opening 106 has elastic properties conferred by the textile characteristics of the mesh wall 102 (e.g., at the rim of the opening) such that a surgical implant may be placed in theenclosure 106 by forcibly widening opening and inserting the implant. The implant is then trapped by the retraction of the opening. This embodiment may or may not include a drawstring. - As shown in
FIGS. 1-4 , in an embodiment, themesh pouch 100 includes one or more extensions, shown in the figures as afirst mesh tab 128 and asecond mesh tab 130. Themesh tabs mesh wall 102 on opposite sides of the widest point of themesh pouch 100. Themesh tabs mesh pouch 100 to interior portions (e.g., internal tissue) of a patient. The pore sizes and pattern of the mesh tabs may vary depending on the embodiment. Two mesh tabs are shown in the drawings, but additional mesh tabs are possible in other embodiments. In this embodiment themesh tabs mesh pouch 100. Other embodiments may have the mesh tabs placed on different planes or at different cross-sectional lengths along the diameter of the mesh pouch. - In an embodiment, the
mesh pouch 100 includes anintegrated strand 132 attached to themesh wall 102. Thestrand 132 has aneedle 134 attached to its terminus. Thestrand 132 may be used to suture themesh pouch 100 to an interior portion of a patient. According to an embodiment, thestrand 132 is connected to one or more of the cords of the mesh wall 102 (either with a sleeve configuration such as thedrawstring 120 or without a sleeve) so that pulling the strand 132 (e.g., while suturing using the strand) has the effect of making theenclosure 104 smaller so that themesh wall 102 fits more snugly onto an implant. Themesh pouch 100 may have multiple such integrated strands with needles. - Turning to
FIG. 5 andFIG. 6 , an example of how themesh pouch 100 is used will now be described. A medical device, such as a breast implant is inserted into themesh pouch 100 through theopening 106. After the medical device is inserted it will be fully encased inside themesh wall 104. Thedrawstring 120 is pulled such that theopening 106 becomes increasingly small as thedrawstring 120 is pulled tighter until it is tight. Thedrawstring 120 is then cinched. The implant may be held within themesh pouch 100 due to the elastic recoil of themesh wall 102, or more firmly by closure of opening 106 with thedrawstring 120. The resting shape of themesh wall 102 may force a round implant enclosed in this way to take on a more natural breast shape. - The implant within the
mesh pouch 100 can then be placed in the appropriate position and appropriate tissue plane as it would be without the mesh pouch 100 (between the skin and the pectoralis/fascia in the setting of prepectoral breast reconstruction, for example). However, after placement, theintegrated mesh tabs mesh pouch 100 to the chest wall provides a way to localize the implant without having to rely on soft tissue manipulation, and the position of the tabs distant from the breast prosthesis minimizes the risk of accidental damage to the breast prosthesis during this process. Positioning and shaping may be further facilitated by the use of the integrated needle 134 (or needles, if there are multiple) to suture to the chest wall, which (if integrated with themesh wall 102 as described above) also cinches down or tailors themesh pouch 100 as desired by the tightening of strands (e.g., integrated fibers) to which the integrated needles are attached. Finally, the overlying layers (skin and subcutaneous tissue, for example), are closed. The weight of the implant is borne by themesh pouch 100 and the soft tissue to which it is sutured, rather than the skin envelope that is covering it. - According to an embodiment, the
mesh pouch 100 is formed as follows: 1) A mesh sheet is formed by warp knitting, electrospinning, or other textile technique. 2) A thermally conductive mold or mandril is formed in a desired spheroid or breast shape. 3) The mesh is wrapped around and annealed to the mold or mandril to the desired spheroid or breast shape. - The
mesh pouch 100 may have uses in multiple domains of breast surgery, such as direct-to-implant, prepectoral, breast reconstruction for a mastectomy defect. In this setting, recreation of the breast mound is performed by placing a prosthetic breast implant in the plane between the pectoralis muscle and the overlying skin, in the space where breast tissue used to reside prior to the mastectomy. For example, inFIG. 5 , there is depicted a mesh-pouched implant 500 (configured according to one or more of the previously described embodiments) disposed in situ in a human breast, with aretractor 502 also shown. InFIG. 6 , there is depicted a mesh-pouched implant 600 (configured according to one or more of the previously described embodiments) disposed in situ in a human breast with amesh tab 602 sutured in place. The various tissue shown inFIG. 6 includes skin andsubcutaneous tissue 604,pectoralis 606,ribs 608, and intercostals 610. - It should be understood that the embodiments described herein should be considered in a descriptive sense only and not for purposes of limitation. Descriptions of features or aspects within each embodiment should typically be considered as available for other similar features or aspects in other embodiments. It will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from their spirit and scope.
Claims (14)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/520,879 US20190343620A1 (en) | 2017-11-13 | 2019-07-24 | Mesh pouch for medical implant |
PCT/US2020/041790 WO2021015976A1 (en) | 2017-11-13 | 2020-07-13 | Mesh pouch for medical implant |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762585402P | 2017-11-13 | 2017-11-13 | |
US16/186,785 US10363127B2 (en) | 2017-11-13 | 2018-11-12 | Mesh pouch for medical implant and method for using same |
US16/520,879 US20190343620A1 (en) | 2017-11-13 | 2019-07-24 | Mesh pouch for medical implant |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/186,785 Continuation-In-Part US10363127B2 (en) | 2017-11-13 | 2018-11-12 | Mesh pouch for medical implant and method for using same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190343620A1 true US20190343620A1 (en) | 2019-11-14 |
Family
ID=66431568
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/186,785 Active US10363127B2 (en) | 2017-11-13 | 2018-11-12 | Mesh pouch for medical implant and method for using same |
US16/520,879 Abandoned US20190343620A1 (en) | 2017-11-13 | 2019-07-24 | Mesh pouch for medical implant |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/186,785 Active US10363127B2 (en) | 2017-11-13 | 2018-11-12 | Mesh pouch for medical implant and method for using same |
Country Status (6)
Country | Link |
---|---|
US (2) | US10363127B2 (en) |
EP (1) | EP3709933A4 (en) |
KR (1) | KR102218426B1 (en) |
CN (1) | CN111683624A (en) |
BR (1) | BR112020009087B1 (en) |
WO (2) | WO2019094861A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021194555A1 (en) * | 2020-03-23 | 2021-09-30 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US20220000604A1 (en) * | 2020-07-01 | 2022-01-06 | Mentor Worldwide Llc | Encoded cinching mechanism for use with an implant delivery sleeve |
US20220008192A1 (en) * | 2020-07-10 | 2022-01-13 | Vanderbilt University | Device for support and shape of soft tissue |
US20220125575A1 (en) * | 2020-10-23 | 2022-04-28 | Andrew Weems | Void occlusion device |
US11638640B2 (en) | 2014-06-11 | 2023-05-02 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11759306B2 (en) | 2018-03-12 | 2023-09-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11883275B2 (en) | 2014-06-11 | 2024-01-30 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11903814B2 (en) | 2018-03-06 | 2024-02-20 | Mentor Worldwide Llc | Delivery sleeve |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR122019027590B1 (en) | 2011-03-09 | 2020-09-15 | Tepha, Inc | MASTOPEXY IMPLANT |
WO2015006737A1 (en) | 2013-07-11 | 2015-01-15 | Tepha, Inc. | Absorbable implants for plastic surgery |
USD836778S1 (en) | 2015-10-09 | 2018-12-25 | Tepha, Inc. | Three dimensional mastopexy implant |
US10932899B2 (en) * | 2017-10-09 | 2021-03-02 | Innovellum, Llc | Apparatus, system and methods for improved breast surgery with myointegration |
BR112020009087B1 (en) * | 2017-11-13 | 2021-06-08 | Surgical Innovation Associates, Inc | mesh bag to hold a surgical implant |
USD889655S1 (en) | 2018-02-09 | 2020-07-07 | Tepha, Inc. | Three dimensional mastopexy implant |
WO2019156870A2 (en) | 2018-02-09 | 2019-08-15 | Tepha, Inc. | Full contour breast implant |
USD889654S1 (en) | 2018-02-09 | 2020-07-07 | Tepha, Inc. | Three dimensional mastopexy implant |
KR20210009302A (en) | 2018-03-13 | 2021-01-26 | 플라비오 나니 | A mesh or membrane covering made of a biological or biosynthetic material for the prosthesis and comprising a system for fixation on the prosthesis, and a method for manufacturing the corresponding |
USD892329S1 (en) | 2018-07-03 | 2020-08-04 | Tepha, Inc. | Three dimensional mastopexy implant |
CA3109394A1 (en) | 2018-10-02 | 2020-04-09 | Tepha, Inc. | Medical devices to limit movement of breast implants |
BR112022010124A2 (en) | 2019-11-25 | 2022-09-06 | Tepha Inc | BREAST IMPLANT WRAPS TO LIMIT BREAST IMPLANT MOVEMENT AND RELATED METHODS |
KR20230148015A (en) * | 2022-04-15 | 2023-10-24 | 주식회사 티앤알바이오팹 | Scaffold for breast reconstruction |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2639035A (en) * | 1947-10-22 | 1953-05-19 | Pearlstein Joseph | Sifting and straining device |
US4428375A (en) * | 1982-02-16 | 1984-01-31 | Ellman Barry R | Surgical bag for splenorrhaphy |
US5282856A (en) * | 1987-12-22 | 1994-02-01 | Ledergerber Walter J | Implantable prosthetic device |
JPH08196538A (en) * | 1994-09-26 | 1996-08-06 | Ethicon Inc | Tissue sticking apparatus for surgery with elastomer component and method of attaching mesh for surgery to said tissue |
US6398814B1 (en) * | 1998-09-14 | 2002-06-04 | Bionx Implants Oy | Bioabsorbable two-dimensional multi-layer composite device and a method of manufacturing same |
US20020165596A1 (en) * | 2001-03-14 | 2002-11-07 | Wilson Chris Edward | Bone graft and implantable fusion stimulator positioning device |
US20110009960A1 (en) | 2001-11-16 | 2011-01-13 | Allergan, Inc. | Prosthetic fabric structure |
FR2857578B1 (en) * | 2003-07-18 | 2007-02-09 | Cie Eu Etude Rech Dispositifs | INTRODUCTION KIT FOR A PLASTIC SURGERY IMPLANT, CASE FOR INTRODUCING SUCH AN IMPLANT AND METHOD OF MANUFACTURING THE SAME |
US9486560B2 (en) * | 2006-02-08 | 2016-11-08 | Tyrx, Inc. | Mesh pouches for implantable medical devices |
US8315700B2 (en) * | 2006-02-08 | 2012-11-20 | Tyrx, Inc. | Preventing biofilm formation on implantable medical devices |
EP2190382B1 (en) * | 2007-09-19 | 2018-10-24 | Ethicon, Inc | Naturally contoured, preformed, three dimensional mesh device for breast implant support |
US20100217388A1 (en) | 2007-10-16 | 2010-08-26 | Orbix Medical Ltd | System and method for reshaping soft tissue |
US20130304098A1 (en) * | 2008-12-15 | 2013-11-14 | Allergan, Inc. | Silk medical device for use in breast augmentation and breast reconstruction |
BRPI0805495A2 (en) * | 2008-12-19 | 2010-09-08 | Miranda Jose Maria De | silicone implant with expandable and / or interactive compartments, whether or not lined with ricinus communis polyurethane foam and / or hydroxyapatite, with tabs or cords |
US20110106249A1 (en) * | 2009-09-02 | 2011-05-05 | Hilton Becker | Self supporting and forming breast implant and method for forming and supporting an implant in a human body |
JP5952198B2 (en) * | 2011-02-04 | 2016-07-13 | Hoya株式会社 | Surgical tools |
BR122019027590B1 (en) | 2011-03-09 | 2020-09-15 | Tepha, Inc | MASTOPEXY IMPLANT |
GB201113303D0 (en) * | 2011-08-02 | 2011-09-14 | Xiros Ltd | Connective tissue repair pad |
CA2900682A1 (en) * | 2013-03-15 | 2014-09-25 | Allergan, Inc. | Silk medical device for use in breast augmentation and breast reconstruction |
US9655715B2 (en) * | 2013-07-11 | 2017-05-23 | Tepha, Inc. | Absorbable implants for plastic surgery |
GB201321033D0 (en) * | 2013-11-28 | 2014-01-15 | Queens University Of The Belfast | Removal of free fatty acids from crude palm oil |
EP2915505B1 (en) * | 2014-03-07 | 2018-01-10 | Novus Scientific AB | Support device used in medical breast reconstruction |
US9913711B2 (en) * | 2014-06-11 | 2018-03-13 | Robert D. Rehnke | Internal long term absorbable matrix brassiere |
JP6961483B2 (en) * | 2014-09-04 | 2021-11-05 | デューク ユニバーシティ | Embedded mesh and how to use it |
EP2995278A1 (en) | 2014-09-09 | 2016-03-16 | Klinikum rechts der Isar der Technischen Universität München | Medical/surgical implant |
EP3236883B1 (en) * | 2014-12-24 | 2022-05-04 | C. R. Bard, Inc. | Implantable prosthesis for soft tissue repair |
WO2016186803A1 (en) | 2015-05-15 | 2016-11-24 | Lifecell Corporation | Tissue matrices for plastic surgery |
BR112020009087B1 (en) * | 2017-11-13 | 2021-06-08 | Surgical Innovation Associates, Inc | mesh bag to hold a surgical implant |
-
2018
- 2018-11-12 BR BR112020009087-5A patent/BR112020009087B1/en active IP Right Grant
- 2018-11-12 WO PCT/US2018/060281 patent/WO2019094861A1/en active Search and Examination
- 2018-11-12 CN CN201880085471.3A patent/CN111683624A/en active Pending
- 2018-11-12 EP EP18876513.5A patent/EP3709933A4/en not_active Withdrawn
- 2018-11-12 US US16/186,785 patent/US10363127B2/en active Active
- 2018-11-12 KR KR1020207016632A patent/KR102218426B1/en active IP Right Grant
-
2019
- 2019-07-24 US US16/520,879 patent/US20190343620A1/en not_active Abandoned
-
2020
- 2020-07-13 WO PCT/US2020/041790 patent/WO2021015976A1/en active Application Filing
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11638640B2 (en) | 2014-06-11 | 2023-05-02 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11969337B2 (en) | 2014-06-11 | 2024-04-30 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11883275B2 (en) | 2014-06-11 | 2024-01-30 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11903814B2 (en) | 2018-03-06 | 2024-02-20 | Mentor Worldwide Llc | Delivery sleeve |
US11844682B2 (en) | 2018-03-12 | 2023-12-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11883276B2 (en) | 2018-03-12 | 2024-01-30 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11759306B2 (en) | 2018-03-12 | 2023-09-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11844683B2 (en) | 2018-03-12 | 2023-12-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US12029641B2 (en) | 2020-03-23 | 2024-07-09 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11759307B2 (en) | 2020-03-23 | 2023-09-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
EP4125715A4 (en) * | 2020-03-23 | 2024-04-17 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
WO2021194555A1 (en) * | 2020-03-23 | 2021-09-30 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11844684B2 (en) | 2020-03-23 | 2023-12-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11844685B2 (en) | 2020-03-23 | 2023-12-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11844686B2 (en) | 2020-03-23 | 2023-12-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11786360B2 (en) * | 2020-07-01 | 2023-10-17 | Mentor Worldwide Llc | Encoded cinching mechanism for use with an implant delivery sleeve |
US20220000604A1 (en) * | 2020-07-01 | 2022-01-06 | Mentor Worldwide Llc | Encoded cinching mechanism for use with an implant delivery sleeve |
US20220008192A1 (en) * | 2020-07-10 | 2022-01-13 | Vanderbilt University | Device for support and shape of soft tissue |
US20220125575A1 (en) * | 2020-10-23 | 2022-04-28 | Andrew Weems | Void occlusion device |
US11602426B2 (en) * | 2020-10-23 | 2023-03-14 | Andrew Weems | Void occlusion device |
US20230172703A1 (en) * | 2020-10-23 | 2023-06-08 | Andrew Weems | Void occlusion device |
Also Published As
Publication number | Publication date |
---|---|
BR112020009087B1 (en) | 2021-06-08 |
WO2021015976A1 (en) | 2021-01-28 |
BR112020009087A2 (en) | 2020-08-18 |
US10363127B2 (en) | 2019-07-30 |
EP3709933A4 (en) | 2021-11-10 |
KR102218426B1 (en) | 2021-02-22 |
KR20200078644A (en) | 2020-07-01 |
WO2019094861A1 (en) | 2019-05-16 |
EP3709933A1 (en) | 2020-09-23 |
CN111683624A (en) | 2020-09-18 |
US20190142573A1 (en) | 2019-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10363127B2 (en) | Mesh pouch for medical implant and method for using same | |
US10603153B2 (en) | Hernia patch | |
US20110106249A1 (en) | Self supporting and forming breast implant and method for forming and supporting an implant in a human body | |
US8197542B2 (en) | Self supporting implant in a human body and method for making the same without capsular contracture | |
US9433489B2 (en) | Absorbable synthetic braided matrix for breast reconstruction and hernia repair | |
US20110054604A1 (en) | Self supporting and forming breast implant and method for forming and supporting an implant in a human body | |
BR112013020638B1 (en) | MASTOPEXY IMPLANT | |
EP3117800A1 (en) | Self-supporting prothesis for plastic and reconstructive surgery | |
US7938122B2 (en) | Device and method for nipple reconstruction | |
EA013782B1 (en) | Soft tissue support | |
US20200367988A1 (en) | Systems and methods for a tissue expander | |
AU2013219907A1 (en) | Implant for hernia repair | |
US20120209301A1 (en) | Implant for hernia repair | |
KR20190062449A (en) | Apparatus and method for elevating or restraining a body part | |
US20240277467A1 (en) | Methods and implantable prosthesis for reconstruction and/or augmentation of an anatomical feature | |
US20140236197A1 (en) | Implant for hernia repair | |
US11298220B2 (en) | Breast treatment device | |
JP6506403B2 (en) | Resorbable and biocompatible PGA implant for implant after excision of IPP plaques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SURGICAL INNOVATION ASSOCIATES, INC., ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MLODINOW, ALEXEI;YERNENI, KETAN;CRUIKSHANK, TODD;REEL/FRAME:049848/0618 Effective date: 20190723 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |